Evaluation of acute hypolipidemic activity of different plant extracts in triton WR-1339 induced hyperlipidemia in albino rats

Pharmacologyonline

Volumn 3, Issue , 2011, Pages 925-934

  Mishra, Piyush Ranjan ^a   Panda, Prasanna Kumar ^b   Chowdary, Korla Apanna ^c   Panigrahi, Saswati ^d  

^a Roland Institute of Pharmaceutical Sciences   (India)

^b UTKAL UNIVERSITY   (India)

^c Andhra University Cantonment   (India)

^d Department of Pharmaceutics   (India)

Author keywords

Anti hyperlipidimic activity; Atorvastatin; Paederia foetida; Randia dumetorum

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; PAEDERIA FOETIDA EXTRACT; PLANT EXTRACT; RANDIA DUMETORUM EXTRACT; TRIACYLGLYCEROL; TYLOXAPOL; UNCLASSIFIED DRUG;

ANALYTICAL EQUIPMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG ISOLATION; DRUG SCREENING; FRUIT; HYPERLIPIDEMIA; HYPOLIPIDEMIC ACTIVITY; LD 50; MALE; NONHUMAN; PAEDERIA FOETIDA; PHYTOCHEMISTRY; RANDIA DUMETORUM; RAT; RUBIACEAE; SINGLE DRUG DOSE; SOXHLET EXTRACTION; TOXICITY TESTING; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84857000145     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. n, The Mcgraw Hill Companies, USA, 2007; 98-108.
2. Diaz MN, Frei B, Vita JA, John F, Keaney Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408-416.
3. Parthasarthy S, Steinberg D, Seitztum JL. The role of oxidized low-density lipoprotein in the pathogenesis of atherosclerosis. Ann Rev Med 1992; 43: 219-225.
4. Dahanukar SA, Kulkarni RA, Rege NN. Pharmacology of medicinal plants and natural products. Indian J Pharmacol 2000; 32: S81-S118.
5. Sircar NON. Pharmacological basis of Ayurvedic therapy. In: Atal CK, Kapoor BM, editors. Cultivation and Utilization of Medicinal Plants. New Delhi, India: Publication and Information Directorate, CSIR; 1992: 507-518.
6. Sklar IV, Kakkar KK, Chakre OJ. Glossary of Indian Medicinal Plants With Active Principles. New Delhi: CSIR; 1992: 75.
7. Umachigi SP, Kumar GS, Jayaveera KN, Kishore Kumar DV, Ashok Kumar CK, Dhanapal R. Antimicrobial, wound healing and antioxidant activities of Anthocephalus Cadamba. Afr J Trad Comp Alt Med 2007; 4: 481-487.
8. Litchfield JT, Jr. and Wilcoxon F. A simplified method of evaluating dose effect. J Pharmac exp Ther 1949; 96(2): 99-113.
9. Schurr PE, Schultz JR, Parkinson TM. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids 1972; 7(1): 68-74.
10. Levine S, Saltzman AA. Procedure for inducing sustained hyperlipemia in rats by administration of a surfactant. J Pharmacol Toxicol Methods 2007; 55(2): 224-226.
11. Borensztajn J, Rone MS, Kotlar TJ. The inhibition in vivo of lipoprotein lipase (clearing- factor lipase) activity by TritonWR-1339. Biochem J 1976; 156: 539-543.
12. Hayashi H, Ninobe S, Matsumoto Y. Effects of Triton WR-1339 on lipoprotein lipolytic activity and lipid content of rat liver lysosomes. J Biochem 1981; 89: 573-579.
13. Kuroda M, Tanzawa K, Tsujita Y, Endo A. Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in Triton WR-1339-induced hyperlipidemia. Biochemicaet Biophysica Acta 1997; 489: 119-125.
14. Okazaki M, Suzuki M, Oguchi K. Changes in coagulative and fibrinolytic activities in Triton WR-1339-inducedhyperlipidemia in rats. Japan J Pharmacol 1990; 52: 353-361.
15. Vogel G, Vogel WH. Drug discovery and evaluation-Pharmacological Assays. Spriger- Verlag, Berlin, 1997;598.
16. S.L. Brown. Lowered serum cholesterol and low mood. Br Med J 1996; 313: 637-638.